NASDAQ:MNKD
MannKind Corporation Stock News
$4.59
+0 (+0%)
At Close: May 17, 2024
Top Picks 2020- MannKind MNKD
10:00am, Friday, 10'th Jan 2020
Given how things are shaping up for MannKind (MNKD) as we begin 2020, it is once again my Top Pick for speculative investors in the coming year, suggests Nate Pile, editor of Nate's Notes.
Afrezza® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month
01:00pm, Monday, 06'th Jan 2020
MannKind Corporation (MNKD) announced today that its Brazilian partner, Biomm S.A., has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed p
Oppenheimer Initiates Coverage On MannKind with Outperform Rating
12:00am, Tuesday, 24'th Dec 2019MannKind Highlights Publication Of Results In DIABETICMedicine Showing Afrezza Reduced Hypoglycemia
12:00am, Friday, 20'th Dec 2019What Are Penny Stocks, and Can They Make You Money? - Market Realist
07:55pm, Wednesday, 18'th Dec 2019
Newcomers to the stock market often dream of fast profits but don’t have large investing accounts. Then they hear about this thing called “penny stocks.”
MannKind: December MidCap Requirement And Afrezza Losses
12:00am, Thursday, 12'th Dec 2019MannKind: New Loan Structure Leads To Financial Uncertainty
12:00am, Wednesday, 04'th Dec 2019MannKind Corporation to Present at the Piper Jaffray '–st Annual Healthcare Conference
12:00am, Friday, 29'th Nov 2019MannKind Adds New Board Member - What It Means To Investors And Investor Activists
12:00am, Friday, 22'nd Nov 2019MannKind Corporation 2019 Q3 - Results - Earnings Call Presentation
12:00am, Wednesday, 13'th Nov 2019Teva Q3 profit misses estimates, tightens FY19 forecast | AlphaStreet
12:14pm, Thursday, 07'th Nov 2019
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported a wider loss in the third quarter of 2019. The bottom line missed analysts' expectations.
